share_log

Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket

Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket

为什么 Graphite Bio 股票的交易价格下跌了 50%;这里有 20 只股票在盘前走势
Benzinga Real-time News ·  2023/01/06 08:03
Gainers
获胜者
OncoCyte Corporation (NASDAQ:OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products that address larger markets. Spruce Biosciences, Inc. (NASDAQ:SPRB) shares rose 84% to $2.30 in pre-market trading. Spruce Biosciences and Kaken Pharmaceutical reported an exclusive licensing agreement to develop and commercialize Tildacerfont for CAH in Japan. CytomX Therapeutics, Inc. (NASDAQ:CTMX) rose 70.4% to $3.05 in pre-market trading. CytomX and Moderna reported a strategic research collaboration for mRNA-based conditionally activated therapeutics. AMTD Digital Inc. (NYSE:HKD) shares rose 40.2% to $42.00 in pre-market trading...
OncoCyte 公司 纳斯达克股票代码:OCX)在盘前交易中上涨89.2%,至0.70美元。Oncocyte上个月宣布裁员40%以上,以调整团队以开发面向更大市场的关键产品。 云杉生物科学公司 ...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发